Fri Jul 30 16:32:36 SGT 2010  
    SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Walk-in clinic. Appointments not required.
Bring NRIC, Visit Pass or Passport for registration.

Tamiflu® Singapore Clinic

Share |
Summary

Tamiflu® Singapore Clinic: Tamiflu® (oseltamivir) clinic, Singapore. For the prevention/prophylaxis and treatment of flu/influenza. Definitions, references, and latest news.

Description

For Flu Treatment:
  Take 1 dose, twice daily, for 5 days
For Flu Prevention (prophylaxis):
  Take 1 dose, once daily, for 10 days
Adults and Children
  13 yrs. and older 1 Dose = One 75 mg capsule

References


Latest News

[Reflection and Reaction] Solid-organ transplants and the risks of pandemic influenza
Sun, 25 Jul 2010 23:00:00 +0100 | The Lancet Infectious Diseases
In March, 2009, a new strain of influenza A H1N1 was identified in Mexico that rapidly spread and developed into a pandemic affecting millions of people. Influenza A has been recognised as an important pathogen in immunocompromised people. In groups at greatest risk for severe infections, such as recipients of haemopoietic stem-cell transplants, mortality before the availability of neuraminidase inhibitors was 15%. Although morbidity and mortality in more recent studies have been lower, suggesting a positive effect of antiviral therapy with these drugs. The rapid increase of resistance to the neuraminidase inhibitor oseltamivir in non-pandemic H1N1 has been a cause for concern. (Source: The Lancet Infectious Diseases)

Oseltamivir: Development of resistance in H1N1 influenza in an infant: case report
Sun, 25 Jul 2010 05:33:33 +0100 | Reactions
(Source: Reactions)

Oseltamivir/zanamivir: Development of resistance in influenza A H1N1 virus infection: case report
Sun, 25 Jul 2010 05:33:33 +0100 | Reactions
(Source: Reactions)

Pandemic 2009 (A)H1N1 influenza (swine flu) - the Manitoba experience.
Sun, 25 Jul 2010 04:01:29 +0100 | Biochemistry and Cell Biology
Authors: Embree J The pattern of illness associated with the first wave of the pandemic influenza A H1N1 (swine flu) in the spring and early summer of 2009 in regions of the province of Manitoba in Canada was more severe, on a population basis, than any other northern hemisphere jurisdiction outside of Mexico City. Manitoba accounted for 50% of intensive care admissions and 25% of pediatric admissions, but only 6.5% of deaths, attributable to the virus in Canada during the first wave. Activation and use of emergency response protocols embedded within the routine health authority management system and good communication between the diagnostic laboratory, public health, and health care practitioners was effective in coping with the sudden need for hospitalization of large numbers of chil...

Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia
Fri, 23 Jul 2010 12:09:41 +0100 | Medical Oncology
We report a HCL patient with A pandemic 2009-H1N1-associated pneumonia who fully recovered after oseltamivir and antibiotics. The subsequent treatment with single 5-day course of 2-CdA resulted in persistent marrow aplasia with fatal systemic aspergillosis. Content Type Journal ArticleCategory Original paperDOI 10.1007/s12032-010-9626-9Authors Grzegorz Helbig, Silesian Medical University Department of Haematology and Bone Marrow Transplantation Dabrowski Street 25 40-032 Katowice PolandKrzysztof Woźniczka, Silesian Medical University Department of Haematology and Bone Marrow Transplantation Dabrowski Street 25 40-032 Katowice PolandAgata Wieczorkiewicz, Silesian Medical University Department of Haematology and Bone Marrow Transplantation Dabrowski Street 25 40-032 Katowice Poland...

Clinical features of hospitalised children with 2009 H1N1 influenza virus infection
Fri, 23 Jul 2010 11:02:41 +0100 | European Journal of Pediatrics
In conclusions, 2009 H1N1 influenza virus infection in children is associated with a wide spectrum of clinical manifestations. Neurological disorders are not exceptional complications. Oseltamivir therapy seems safe also in infants. Content Type Journal ArticleCategory Original PaperDOI 10.1007/s00431-010-1255-yAuthors Carmelina Calitri, University of Turin, Regina Margherita Children’s Hospital Department of Paediatrics Piazza Polonia 94 10126 Turin ItalyClara Gabiano, University of Turin, Regina Margherita Children’s Hospital Department of Paediatrics Piazza Polonia 94 10126 Turin ItalySilvia Garazzino, University of Turin, Regina Margherita Children’s Hospital Department of Paediatrics Piazza Polonia 94 10126 Turin ItalyMichele Pinon, University of Turin, Regina Margherit...

Oseltamivir: Confusion and hallucinations: case report
Fri, 23 Jul 2010 05:32:26 +0100 | Reactions
(Source: Reactions)

Safety of Oseltamivir in Pregnancy: A Review of Preclinical and Clinical Data
Fri, 23 Jul 2010 05:32:24 +0100 | Drug Safety
(Source: Drug Safety)

Influenza A (H1N1) virus-induced hepatocellular injury in a kidney transplant patient
Thu, 22 Jul 2010 23:00:00 +0100 | Transplant Infectious Disease
M. Daudé, J.M. Mansuy, J. Guitard, G. Basse, L. Esposito, J. Izopet, L. Rostaing, N. Kamar. Influenza A (H1N1) virus-induced hepatocellular injury in a kidney transplant patient.Transpl Infect Dis 2010. All rights reserved.Abstract: The swine-origin influenza A (H1N1) virus is mainly responsible for flu. No hepatitis attributable to H1N1 virus has been previously documented. Herein, we report on a kidney transplant patient who developed influenza H1N1 virus-induced hepatocellular injury. The patient's body temperature was only somewhat elevated, and pulmonary and flu symptoms were mild. H1N1 virus was detected by polymerase chain reaction assay in nasopharyngeal and bronchoalveolar swabs, as well as in the serum. The hepatocellular injury episode resolved after the patient had been placed...